ANDA 209303, held by Alignscience Pharma. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 209303 (Metformin Hydrochloride), held by Alignscience Pharma, was first approved by FDA on Mar 19, 2018, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 19, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride500MG · tablet, extended release;oral | Metformin Hydrochloride | Rx |
| Aug 11, 2026 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 14, 2019 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jan 2, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Mar 19, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters